HopeStage
Back to all studies
CompletedNCT03207048

A Study of Repetitive Transcranial Magnetic Stimulation in Bipolar Patients

Device studyAges 18–60ChinaBipolarity
The study in practice

Understand this study

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.

Listed locations
Guangzhou, ChinaSee all locations and recruitment
Activities
Device procedures described in the protocol · Sham comparator
Compensation
Payment and expense reimbursement have not been verified.
Study clarity

Study information

Study start dateStarted: July 10, 2017
Recruitment status
Completed
Enrollment listed in the registry
42
Sponsor
Guangzhou Psychiatric Hospital
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
China
Age range
From 18 Years to 60 Years
Official registry ID
NCT03207048
Official title
Show the full official title

Repetitive Transcranial Magnetic Stimulation (rTMS) to Improve Cognitive Function and Prevent Relapses in Bipolar Patients

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Guangzhou

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Guangzhou Psychiatric Hospital, a hospital or academic medical center.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me